PT1073416E - Utilização de óxido nítrico inalado como agente anti-inflamatório - Google Patents

Utilização de óxido nítrico inalado como agente anti-inflamatório Download PDF

Info

Publication number
PT1073416E
PT1073416E PT98953702T PT98953702T PT1073416E PT 1073416 E PT1073416 E PT 1073416E PT 98953702 T PT98953702 T PT 98953702T PT 98953702 T PT98953702 T PT 98953702T PT 1073416 E PT1073416 E PT 1073416E
Authority
PT
Portugal
Prior art keywords
inhaled
inflammatory agent
inflammatory
agent
Prior art date
Application number
PT98953702T
Other languages
English (en)
Inventor
Warren M Zapol
Kenneth D Bloch
Anthony Rosenzweig
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26742873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1073416(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of PT1073416E publication Critical patent/PT1073416E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
PT98953702T 1997-10-21 1998-10-19 Utilização de óxido nítrico inalado como agente anti-inflamatório PT1073416E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6292697P 1997-10-21 1997-10-21
US08/971,003 US6656452B1 (en) 1997-10-21 1997-11-14 Use of inhaled NO as anti-inflammatory agent

Publications (1)

Publication Number Publication Date
PT1073416E true PT1073416E (pt) 2009-03-17

Family

ID=26742873

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98953702T PT1073416E (pt) 1997-10-21 1998-10-19 Utilização de óxido nítrico inalado como agente anti-inflamatório

Country Status (13)

Country Link
US (2) US6656452B1 (pt)
EP (1) EP1073416B1 (pt)
JP (1) JP2003532615A (pt)
AR (1) AR015973A1 (pt)
AT (1) ATE421874T1 (pt)
AU (1) AU751853B2 (pt)
CA (1) CA2309038C (pt)
CY (1) CY1110228T1 (pt)
DE (1) DE69840526D1 (pt)
DK (1) DK1073416T3 (pt)
ES (1) ES2319240T3 (pt)
PT (1) PT1073416E (pt)
WO (1) WO1999020251A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US20030070674A1 (en) * 2001-10-12 2003-04-17 Bryan Perry Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
AU2003265239A1 (en) * 2002-05-22 2003-12-19 Virginia Commonwealth University Protective effects of pde-5 inhibitors
WO2003105872A1 (de) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Xenonhaltiges spasmolytikum
MXPA04012863A (es) * 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007130725A2 (en) * 2006-02-06 2007-11-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of hmgb1 for protection against ischemia reperfusion injury
US8887721B2 (en) * 2006-11-07 2014-11-18 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
US8435569B2 (en) 2007-04-30 2013-05-07 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
WO2010049423A1 (en) * 2008-10-27 2010-05-06 Life Sciences Research Partners Vzw Effects of nitric oxide inhalation on long-term myocardial reperfusion injury
ES2966234T3 (es) 2009-06-09 2024-04-18 Prolong Pharmaceuticals Llc Composiciones de hemoglobina
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
CA2819854A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
CA3003708C (en) 2011-10-03 2019-01-15 NitricGen, Inc. Apparatus and method for generating nitric oxide in controlled and accurate amounts
US9572833B2 (en) 2011-11-07 2017-02-21 The General Hospital Corporation Treatment of red blood cells
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2023190532A1 (ja) * 2022-03-29 2023-10-05 康太郎 木田 横紋筋融解症を治療するための医薬組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1516639T4 (en) * 1990-12-05 2015-06-29 Gen Hospital Corp Use of NO to treat persistent pulmonary hypertension in newborns
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5536241A (en) 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
EP0726768B1 (en) 1993-11-02 2000-05-17 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, Department of Health and Human Services Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
US5521191A (en) 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
ATE331505T1 (de) 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation

Also Published As

Publication number Publication date
CY1110228T1 (el) 2015-01-14
US6811768B2 (en) 2004-11-02
DE69840526D1 (de) 2009-03-19
DK1073416T3 (da) 2009-03-09
US6656452B1 (en) 2003-12-02
ATE421874T1 (de) 2009-02-15
CA2309038A1 (en) 1999-04-29
ES2319240T3 (es) 2009-05-05
EP1073416A1 (en) 2001-02-07
EP1073416B1 (en) 2009-01-28
CA2309038C (en) 2009-04-21
AU1101299A (en) 1999-05-10
JP2003532615A (ja) 2003-11-05
AU751853B2 (en) 2002-08-29
AR015973A1 (es) 2001-05-30
WO1999020251A1 (en) 1999-04-29
EP1073416A4 (en) 2004-07-07
US20040096523A1 (en) 2004-05-20

Similar Documents

Publication Publication Date Title
PT1073416E (pt) Utilização de óxido nítrico inalado como agente anti-inflamatório
IL133672A0 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1017379A4 (en) THERAPEUTIC COMPOSITIONS
GB9726916D0 (en) Nasal formulation
HUP0104574A3 (en) Analogues of glp-1, pharmaceutical compositions comprising thereof and their use
ZA9878B (en) New formulation for inhalation
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
AU9757398A (en) Novel compounds derived from menthol and use as refreshing agent
EP0976407A4 (en) ANTISEPTIC COMPOSITIONS
HUP0100102A3 (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
PL349137A1 (en) Use of cholesterol-lowering agent
IL134210A0 (en) Use of transcription factor brn-3a
HUP0003845A3 (en) Use of 8a-azalides as antimicrobial agents
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9705989D0 (en) Therapeutic composition
ZA989550B (en) Use of inhaled no as anti-inflammatory agent.
ZA981729B (en) Use of pivagabin to prepare pharmaceutical compositions
GB9817348D0 (en) Pharmaceutical use of esters
AU3702099A (en) The use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles
GB9722026D0 (en) Use of compounds
GB9921062D0 (en) Use of cholestrol-lowering agent